Author
Naiyer A. Rizvi
Also Known As
Grohe, Christian, N A Rizvi, N Rizvi, N. A. Rizvi, N. Rizvi, N.A. Rizvi, Naiyer A Rizvi, Naiyer A. Rizvi, Naiyer Rizvi, Noor Rizvi
470
Publications
64.4K
Citations
81
H-Index
116
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 49 | 133 | 20.1K |
2 | Health Sciences | 19 | 27 | 1.9K |
3 | Natural Sciences | 2 | 2 | 60 |
4 | Public Health | 2 | 2 | 45 |
5 | Engineering | 1 | 1 | 301 |
Naiyer A. Rizvi
×
211
Publications
62.6K
Citations
78
H-Index
| Year | Citations | |
|---|---|---|
2015 | 9.3K | |
2015 | 7.8K | |
2015 | 6.1K | |
2019 | 4.2K | |
2013 | 4.2K | |
2016 | 3K | |
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial Naiyer A. Rizvi, Julien Mazières, David Planchard, Checkmate 063Single-arm TrialMedicineImmunologyImmune Checkpoint Inhibitor | 2015 | 1.4K |
2015 | 1.2K | |
2017 | 1.1K | |
2016 | 1K |
Page 1
Page 1